Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


30.12.2018

1 Cereb Cortex
2 Compr Psychiatry
2 J Nerv Ment Dis
1 Neuropsychopharmacology
10 Psychiatry Res
2 Psychol Med
11 Schizophr Res


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Cereb Cortex

  1. YANG JM, Shen CJ, Chen XJ, Kong Y, et al
    erbb4 Deficits in Chandelier Cells of the Medial Prefrontal Cortex Confer Cognitive Dysfunctions: Implications for Schizophrenia.
    Cereb Cortex. 2018 Dec 22. pii: 5257441. doi: 10.1093.
    PubMed     Text format     Abstract available


    Compr Psychiatry

  2. BANI-FATEMI A, Tasmim S, Graff A, Gerretsen P, et al
    The effect of ethnicity and immigration on treatment resistance in schizophrenia.
    Compr Psychiatry. 2018;89:28-32.
    PubMed     Text format     Abstract available

  3. XUE SW, Yu Q, Guo Y, Song D, et al
    Resting-state brain entropy in schizophrenia.
    Compr Psychiatry. 2018;89:16-21.
    PubMed     Text format     Abstract available


    J Nerv Ment Dis

  4. WESTERMEYER J
    Call for "High-Dose" Olanzapine Research in Treatment-Resistant Psychosis.
    J Nerv Ment Dis. 2019;207:45-47.
    PubMed     Text format     Abstract available

  5. RITSNER MS, Ratner Y
    Predicting Predischarge Anhedonia Among Inpatients With Schizophrenia and Schizoaffective Disorders: A Large-scale Analysis.
    J Nerv Ment Dis. 2019;207:12-21.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  6. BRUCATO G, Appelbaum PS, Masucci MD, Rolin S, et al
    Prevalence and phenomenology of violent ideation and behavior among 200 young people at clinical high-risk for psychosis: an emerging model of violence and psychotic illness.
    Neuropsychopharmacology. 2018 Dec 27. pii: 10.1038/s41386-018-0304.
    PubMed     Text format     Abstract available


    Psychiatry Res

  7. WANG D, Cheng SL, Fei Q, Gu H, et al
    Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia.
    Psychiatry Res. 2018;272:18-29.
    PubMed     Text format     Abstract available

  8. HUANG N, Cao B, Brietzke E, Park C, et al
    A pilot case-control study on the association between N-acetyl derivatives in serum and first-episode schizophrenia.
    Psychiatry Res. 2018;272:36-41.
    PubMed     Text format     Abstract available

  9. HE Y, Li Z, Ma X, Yuan L, et al
    Olfactory and cognitive functions in Chinese individuals at clinical high risk for psychosis.
    Psychiatry Res. 2018;272:51-53.
    PubMed     Text format     Abstract available

  10. TAN EJ, Fletcher K, Rossell SL
    Exploring the relationship between fantasy proneness and delusional beliefs in psychosis and non-clinical individuals.
    Psychiatry Res. 2018;272:80-85.
    PubMed     Text format     Abstract available

  11. KENT JS, Caligiuri MP, Skorheim MK, Lano TJ, et al
    Instrument-based assessment of motor function yields no evidence of dyskinesia in adult first-degree biological relatives of individuals with schizophrenia and schizoaffective disorder.
    Psychiatry Res. 2018;272:135-140.
    PubMed     Text format     Abstract available

  12. WANG YY, Wang S, Zheng W, Zhong BL, et al
    Cognitive functions in smoking and non-smoking patients with schizophrenia: A systematic review and meta-analysis of comparative studies.
    Psychiatry Res. 2018;272:155-163.
    PubMed     Text format     Abstract available

  13. ENGELSTAD KN, Rund BR, Torgalsboen AK, Lau B, et al
    Large social cognitive impairments characterize homicide offenders with schizophrenia.
    Psychiatry Res. 2018;272:209-215.
    PubMed     Text format     Abstract available

  14. FOUNTOULAKIS KN, Panagiotidis P, Kimiskidis V, Nimatoudis I, et al
    Neurological soft signs in familial and sporadic schizophrenia.
    Psychiatry Res. 2018;272:222-229.
    PubMed     Text format     Abstract available

  15. THAI ML, Andreassen AK, Bliksted V
    A meta-analysis of executive dysfunction in patients with schizophrenia: Different degree of impairment in the ecological subdomains of the Behavioural Assessment of the Dysexecutive Syndrome.
    Psychiatry Res. 2018;272:230-236.
    PubMed     Text format     Abstract available

  16. STRAMECKI F, Kotowicz K, Piotrowski P, Beszlej JA, et al
    Coping styles and symptomatic manifestation of first-episode psychosis: Focus on cognitive performance.
    Psychiatry Res. 2018;272:246-251.
    PubMed     Text format     Abstract available


    Psychol Med

  17. WATERS F, Blom JD, Jardri R, Hugdahl K, et al
    Auditory hallucinations, not necessarily a hallmark of psychotic disorder.
    Psychol Med. 2018;48:529-536.
    PubMed     Text format     Abstract available

  18. AJNAKINA O, David AS, Murray RM
    'At risk mental state' clinics for psychosis - an idea whose time has come - and gone!
    Psychol Med. 2018 Dec 26:1-6. doi: 10.1017/S0033291718003859.
    PubMed     Text format     Abstract available


    Schizophr Res

  19. ZHENG W, Zhu XM, Zhang QE, Yang XH, et al
    Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Schizophr Res. 2018 Dec 17. pii: S0920-9964(18)30695.
    PubMed     Text format     Abstract available

  20. KARAGEORGIOU V, Milas GP, Michopoulos I
    Neutrophil-to-lymphocyte ratio in schizophrenia: A systematic review and meta-analysis.
    Schizophr Res. 2018 Dec 17. pii: S0920-9964(18)30703.
    PubMed     Text format     Abstract available

  21. CLAMOR A, Sundag J, Lincoln TM
    Specificity of resting-state heart rate variability in psychosis: A comparison with clinical high risk, anxiety, and healthy controls.
    Schizophr Res. 2018 Dec 17. pii: S0920-9964(18)30697.
    PubMed     Text format     Abstract available

  22. VARCIN KJ, Nangle MR, Henry JD, Bailey PE, et al
    Intact spontaneous emotional expressivity to non-facial but not facial stimuli in schizophrenia: An electromyographic study.
    Schizophr Res. 2018 Dec 18. pii: S0920-9964(18)30707.
    PubMed     Text format     Abstract available

  23. LUTHER L, Fischer MW, Firmin RL, Salyers MP, et al
    Clarifying the overlap between motivation and negative symptom measures in schizophrenia research: A meta-analysis.
    Schizophr Res. 2018 Dec 18. pii: S0920-9964(18)30612.
    PubMed     Text format     Abstract available

  24. HANSEN MC, Jones BD, Eack SM, Glenthoj LB, et al
    Validation of the MUSIC Model of Motivation Inventory for use with cognitive training for schizophrenia spectrum disorders: A multinational study.
    Schizophr Res. 2018 Dec 20. pii: S0920-9964(18)30688.
    PubMed     Text format     Abstract available

  25. BELLAVIA A, Centorrino F, Jackson JW, Fitzmaurice G, et al
    The role of weight gain in explaining the effects of antipsychotic drugs on positive and negative symptoms: An analysis of the CATIE schizophrenia trial.
    Schizophr Res. 2018 Dec 21. pii: S0920-9964(18)30694.
    PubMed     Text format     Abstract available

  26. KALIUZHNA M, Stein T, Rusch T, Sekutowicz M, et al
    No evidence for abnormal priors in early vision in schizophrenia.
    Schizophr Res. 2018 Dec 23. pii: S0920-9964(18)30723.
    PubMed     Text format     Abstract available

  27. XIE S, Liu B, Wang J, Zhou Y, et al
    Hyperconnectivity in perisylvian language pathways in schizophrenia with auditory verbal hallucinations: A multi-site diffusion MRI study.
    Schizophr Res. 2018 Dec 23. pii: S0920-9964(18)30720.
    PubMed     Text format     Abstract available

  28. MOSLEM M, Olive J, Falk A
    Stem cell models of schizophrenia, what have we learned and what is the potential?
    Schizophr Res. 2018 Dec 23. pii: S0920-9964(18)30719.
    PubMed     Text format     Abstract available

  29. TOVAR A, Fuentes-Claramonte P, Soler-Vidal J, Ramiro-Sousa N, et al
    The linguistic signature of hallucinated voice talk in schizophrenia.
    Schizophr Res. 2018 Dec 17. pii: S0920-9964(18)30689.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: